Oncogenic drivers including RET and ROS1 plus PTEN loss and MET by IHC in patients with lung adenocarcinomas: Lung Cancer Mutation Consortium 2.0 Meeting Abstract


Authors: Johnson, B. E.; Kris, M. G.; Wistuba, I. I.; Berry, L.; Socinski, M. A.; Ramalingam, S. S.; Glisson, B.; Otterson, G.; Schiller, J.; Cetnar, J.; Brahmer, J. R.; Sequist, L. V.; Lovly, C.; Minna, J.; Bunn, P. A. Jr; Kwiatkowski, D. J.; Kugler, K.; Waqar, S.; Politi, K.; Garon, E. B.; Haura, E.
Abstract Title: Oncogenic drivers including RET and ROS1 plus PTEN loss and MET by IHC in patients with lung adenocarcinomas: Lung Cancer Mutation Consortium 2.0
Meeting Title: 16th World Conference on Lung Cancer (WCLC)
Keywords: adenocarcinoma; next generation sequencing; oncogenic driver
Journal Title: Journal of Thoracic Oncology
Volume: 10
Issue: 9 Suppl. 2
Meeting Dates: 2015 Sep 6-9
Meeting Location: Denver, CO
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2015-09-01
Start Page: S295
Language: English
ACCESSION: WOS:000370365101093
PROVIDER: wos
PUBMED: 26710300
DOI: 10.1016/S1556-0864(16)30011-9
Notes: Meeting Abstract: MINI13.03 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark Kris
    869 Kris
Related MSK Work